-
Open Access Journal of Clinical Trials
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Trans fatty acids and coronary artery disease
Review
(2870) Views (980) Full article downloads
Authors: Jocelyne R Benatar
Published Date January 2010
Volume 2010:2 Pages 9 - 13
DOI: http://dx.doi.org/10.2147/OAJCT.S7091
Jocelyne R Benatar
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
Abstract: There has been a significant increased consumption of trans fats in the developed world as we have embraced processed and take away foods in our diet in the last 40 years. These fatty acids are not essential for human nutrition and are hazardous to health. They increase the risk of cardiovascular disease more than any other macronutrient including saturated fat, through multiple mechanisms including adverse effects on lipids, endothelial function and inflammation. They are readily incorporated into cell structures such as cell membranes and the Golgi apparatus, resulting in unintended effects on multiple biological pathways. The majority of trans fats in our diet are artificially manufactured by a process of partial hydrogenation of vegetable oil with little coming from natural sources. It should be possible to replace these harmful fats in the food chain at source with concerted efforts from food manufacturers and legislators.
Keywords: trans fats, coronary artery disease, hydrogenated vegetable oils
Readers of this article also read:
Research methodological issues in evaluating herbal interventions
Pharmacological modeling and biostatistical analysis of a new drug
Clinical data management: Current status, challenges, and future directions from industry perspectives
Examining the readability of patient-informed consent forms
Data retention after a patient withdraws consent in clinical trials
Clinical trials: innovation, progress and controversy
Examining the clinical trial feasibility process and its implications for a trial site
Critical illness outcome study: an observational study of protocols and mortality in intensive care units
Variation in effect of intervention studies in research on sickness absence
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




